AJU IB Investment Co Valuation Multiples

Discover AJU IB Investment Co's revenue and EBITDA valuation multiples and investment history, alongside public comparables like Pengana Private Equity, Foresight VCT, SuRo Capital, Augmentum Fintech and more.

AJU IB Investment Co Overview

About AJU IB Investment Co

AJU IB Investment Co Ltd is the venture capital company in Korea, is an excellent partner that comprehensively supports start-up businesses and IPO of SMEs and venture companies with investment, finance, management, technical support, mergers and acquisitions. By actively investing not only in the Korean but also overseas markets, the company is growing and developing into a global venture and private equity investment company that leads the growth of small and medium-sized venture companies.


Founded

1974

HQ

South Korea

Employees

N/A

Sectors

Financials (FY)

Revenue: $21M
EBITDA: $10M

EV

$232M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

AJU IB Investment Co Financials

AJU IB Investment Co reported last fiscal year revenue of $21M and EBITDA of $10M.

In the same fiscal year, AJU IB Investment Co generated $10M in EBITDA and $6M in net income.


AJU IB Investment Co P&L

In the most recent fiscal year, AJU IB Investment Co reported revenue of $21M and EBITDA of $10M.

AJU IB Investment Co is profitable as of last fiscal year, with EBITDA margin of 49% and net margin of 27%.

See analyst estimates for AJU IB Investment Co
Last FY202320242025202620272028
Revenue$21M$26M$18M$21M
EBITDA$10M$14M$8M$10M
EBITDA Margin49%54%44%49%
Net Profit$6M$11M$6M$6M
Net Margin27%42%31%27%

Financial data powered by Morningstar, Inc.

AJU IB Investment Co Stock Performance

AJU IB Investment Co has current market cap of $275M, and enterprise value of $232M.

Market Cap Evolution


AJU IB Investment Co's stock price is $2.27.

AJU IB Investment Co share price decreased by 27.3% in the last 30 days, and increased by 48.5% in the last year.

AJU IB Investment Co has an EPS (earnings per share) of $0.05.

See more trading valuation data for AJU IB Investment Co
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$232M$275M-0.5%-27.3%-76.2%48.5%$0.05

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

AJU IB Investment Co Valuation Multiples

AJU IB Investment Co trades at 11.0x EV/Revenue multiple, and 22.6x EV/EBITDA.

See NTM and 2027E valuation multiples for AJU IB Investment Co

AJU IB Investment Co Financial Valuation Multiples

As of July 19, 2026, AJU IB Investment Co has market cap of $275M and EV of $232M.

AJU IB Investment Co has a P/E ratio of 49.2x.

Last FY202320242025202620272028
EV/Revenue11.0x8.8x12.8x11.0x
EV/EBITDA22.6x16.1x29.2x22.6x
P/E49.2x24.7x49.2x49.2x
EV/FCF(173.1x)8.0x14.4x(173.1x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified AJU IB Investment Co Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

AJU IB Investment Co Margins & Growth Rates

In the most recent fiscal year, AJU IB Investment Co reported EBITDA margin of 49% and net margin of 27%.

See estimated margins and future growth rates for AJU IB Investment Co

AJU IB Investment Co Margins

Last FY20242025202720282029
EBITDA Margin49%44%49%
Net Margin27%31%27%
FCF Margin(6%)89%(6%)

AJU IB Investment Co Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth(31%)16%
EBITDA Growth(45%)29%
Net Profit Growth(50%)(0%)
FCF Growth(44%)(108%)

Data powered by FactSet, Inc. and Morningstar, Inc.

AJU IB Investment Co Operational KPIs

Access forward-looking KPIs for AJU IB Investment Co
Last FY202320242025202620272028
S&M Expenses to Revenue5%4%7%5%
G&A Expenses to Revenue5%3%7%5%
Opex to Revenue62%54%68%62%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

AJU IB Investment Co Competitors

AJU IB Investment Co competitors include Pengana Private Equity, Foresight VCT, SuRo Capital, Augmentum Fintech, Auroora Group, Brockhaus Technologies, Literacy Capital, Mauá Capital Recebíveis Imobiliários, SK Securities and Kinea Unique Hy Cdi FII.

Most AJU IB Investment Co public comparables operate across PE & VC.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Pengana Private Equity7.0x---
Foresight VCT319.4x---
SuRo Capital-155.5x--
Augmentum Fintech----
Auroora Group1.2x1.2x11.8x12.8x
Brockhaus Technologies7.4x-(18.3x)-
Literacy Capital62.7x---
Mauá Capital Recebíveis Imobiliários8.9x---

This data is available for Pro users. Sign up to see all AJU IB Investment Co competitors and their valuation data.

Start Free Trial

Investments by AJU IB Investment Co

AJU IB Investment Co has invested in 125 companies to date.

Latest investment by AJU IB Investment Co was on June 9th 2026. AJU IB Investment Co invested in Nventric in their $23M Undisclosed stage round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by AJU IB Investment Co

Nventric
MangoBoost
People & Technology
Cenyx Biotech
Description
Nventric is a medical device company developing stents and delivery systems for neurovascular, coronary, and peripheral artery treatments. Its products address aneurysms and blockages in vessels from Singapore manufacturing facilities.
MangoBoost is a Shanghai-headquartered provider of data processing units optimizing AI data centers for GPU compatibility and legacy infrastructure reuse. The MangoBoost DPU supports standards-based networking with research roots in OSDI and ISCA conferences. Established in 2022, the company expands operations in the United States, Canada, and South Korea with a team of systems experts from top institutions.
People & Technology Inc is engaged in manufacturing of special-purpose machinery. It operates the business through film division, battery division, copper division, non-woven division, and water division. Its products include li-ion battery sequential both-side coater, electronic deposition machine, non-woven auto turret winding machine.
Cenyx Biotech is a biotechnology firm developing nanozyme and nanoparticle-based diagnostic and therapeutic compounds. The company engineers nano-compounds for targeted drug delivery and imaging applications from its research base, focusing on unmet needs in oncology and infectious diseases via cenyxbiotech.com.
HQ CountryUnited StatesUnited StatesSouth KoreaSouth Korea
HQ City
Los Angeles, CA
Seattle, WA
Seoul
Seoul
Deal Date9 Jun 202620 Apr 20266 Apr 202630 Mar 2026
RoundUndisclosed stageSeries BUndisclosed stageSeries B
Raised$23M$7M$10M$9M
InvestorsAJU IB Investment Co; Quad Asset Management; Moneyball Ventures; Partner Plexus; Scale Up Partners; IPS Ventures; HB Investment; Moneyball Partners; loftyrock investment; Heungkuk Asset Management; Shinhan Capital; Shinhan Venture InvestmentAJU IB Investment Co; DB Technology Investment; BonAngels Venture Partners; ION Asset Management; Kiwoom Investment; Samsung Venture Investment; KT InvestmentAJU IB Investment Co; Solidus Investment; Bokwang Investment; Dong-A ST; Kiwoom Investment; Wanted Lab Partners; IBK Capital; Cornerstone Investment Partners; Fine Asset ManagementAJU IB Investment Co; Scale Up Partners; CKD Venture Capital Corporation; Intervalue Partners; Partners Investment; SL Investment; SBI Investment KOREA
Valuationundisclosedundisclosedundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all AJU IB Investment Co investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About AJU IB Investment Co

When was AJU IB Investment Co founded?AJU IB Investment Co was founded in 1974.
Where is AJU IB Investment Co headquartered?AJU IB Investment Co is headquartered in South Korea.
Is AJU IB Investment Co publicly listed?Yes, AJU IB Investment Co is a public company listed on Korea Exchange.
What is the stock symbol of AJU IB Investment Co?AJU IB Investment Co trades under 027360 ticker.
When did AJU IB Investment Co go public?AJU IB Investment Co went public in 2018.
Who are competitors of AJU IB Investment Co?AJU IB Investment Co main competitors include Pengana Private Equity, Foresight VCT, SuRo Capital, Augmentum Fintech, Auroora Group, Brockhaus Technologies, Literacy Capital, Mauá Capital Recebíveis Imobiliários, SK Securities, Kinea Unique Hy Cdi FII.
What is the current market cap of AJU IB Investment Co?AJU IB Investment Co's current market cap is $275M.
What is the current revenue of AJU IB Investment Co?AJU IB Investment Co's last fiscal year revenue is $21M.
What is the current EV/Revenue multiple of AJU IB Investment Co?Current revenue multiple of AJU IB Investment Co is 11.0x.
Is AJU IB Investment Co profitable?No, AJU IB Investment Co is not profitable.
How many companies AJU IB Investment Co has acquired to date?AJU IB Investment Co hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies AJU IB Investment Co has invested to date?As of July 2026, AJU IB Investment Co has invested in 125 companies.
What was the last AJU IB Investment Co investment?On 9th June 2026 AJU IB Investment Co invested in Nventric, participating in a $23M Undisclosed stage round, alongside Quad Asset Management, Moneyball Ventures, Partner Plexus, Scale Up Partners, IPS Ventures, HB Investment, Moneyball Partners, loftyrock investment, Heungkuk Asset Management, Shinhan Capital, and 1 other investor.
In what companies AJU IB Investment Co invested in?AJU IB Investment Co invested in LIG Nex1, GI Innovation, Arcellx, DEEPX, Yanolja, Kymera Therapeutics, Amphivena Therapeutics, Bellicum Pharmaceuticals, Seer, Kezar Life Sciences, Apellis Pharmaceuticals, G1 Therapeutics, Synlogic, Fresh Easy, Curocell, Laundrygo, Bagelcode, Aileron Therapeutics, Dreammark One, PGT, and 105 other companies.

See public comps similar to AJU IB Investment Co

Lists including AJU IB Investment Co

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial